- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00849966
Celecoxib for Pediatric Adenotonsillectomy
Celecoxib for Pediatric Adenotonsillectomy: A Randomized Controlled Double Blinded Study
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The study will consist of two arms, one placebo and the other celecoxib. To establish baseline data on the day of surgery the parents will be required to complete a validated parent report quality of life inventory, multi-dimension fatigue scale and pediatric pain questionnaire for the preceding week. Children/adolescents aged 8 to 18 years of age will be required to complete a child self-report of the same modules. Children undergoing adenotonsillectomy will receive either placebo or celecoxib by mouth one hour prior to their surgery. They will all receive preoperative acetaminophen. Premedication with midazolam will be at the discretion of the attending anesthesiologist. The patients will undergo a standardized anesthetic protocol including postoperative management of pain and nausea and vomiting. The patients, while under anesthesia, will have blood drawn to screen for occult liver and kidney disease, determine their CYP2C9 genotype and reserve for future gene chip micro array analysis.
Patients in both study arms will receive a second dose of celecoxib or placebo by mouth in the evening after surgery and then consecutively in the morning and evening for 72 hours. For seven days after the surgery the families will record once a day pain scores, document analgesic use and any side effects or adverse events. The families will be contacted by phone in the evening of the first three postoperative days to ensure that they understand and are completing the required documentation. On the seventh postoperative day the parents and children aged 8 to 18 years of age will be contacted by phone and instructed to complete the same two validated questionnaires concerning quality of life and level of fatigue completed on the day of surgery. Parents of children less than eight years of age will be responsible for completing these questionnaires based on observations of their children. On the 11th postoperative day the families will be contacted by e-mail or regular mail to complete a questionnaire asking about the extent of contact with the healthcare system, bleeding complications, recovery and overall satisfaction with their care.
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 2
Kontakter och platser
Studieorter
-
-
Ontario
-
Ottawa, Ontario, Kanada, ON K1H 8L1
- Children's Hospital of Eastern Ontario
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Children aged 2-18 years
- Tonsillectomy, or adenotonsillectomy
- No exclusion criteria
Exclusion Criteria:
- Age < 2yrs and >18yrs old
- BMI < 10th or > 95th percentile
- Serum creatinine (Cr) > 2 X UNL (upper normal limit)
- Abnormal liver function; namely alanine aminotransferase (ALT) > 1.5 X UNL, alkaline phosphatase (ALP) > 5X UNL, total bilirubin > 2 X UNL
- History of peptic ulcer disease.
- History of bleeding disorders
- History of severe asthma (requiring recent hospital admission or oral corticosteroid therapy)
- Allergy to celecoxib, sulfonamide compounds or NSAIDs
- Patients receiving CYP2C9 inhibitors fluconazole, amiodarone and oxandrolone
- Patients receiving CYP2C9 inducers rifampin and phenobarbital
- Extremes of body mass index (BMI) (age related below10th or above 90th percentile)
- Parents of any participants, irrespective of age, who are unable to read and understand instructions relayed in English or French
- Participant and/or parents of any participants, irrespective of age, who suffer from dementia, psychosis, significant developmental delay or other impairment that would prohibit the understanding and giving of informed consent or assent or the participation in self-care or toxicity reporting
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Fyrdubbla
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Placebo-jämförare: B
Placebo
|
Patients will be randomized to receive celecoxib suspension 6 mg/kg one hour prior to their scheduled surgery. In addition the patient will receive seven weight-based doses of celecoxib (3 mg/kg) to be administered every 10-12 hours while the child is awake; the first dose being administered the evening of surgery. All participants will receive undergo and post surgery anesthetic treatment according to the usual standards of practice at CHEO.
Andra namn:
Patients will be randomized to receive placebo by mouth one hour prior to their scheduled surgery. In addition the patient will receive seven weight-based doses of the placebo to be administered every 10-12 hours while the child is awake; the first dose being administered the evening of surgery. All participants will receive undergo and post surgery anesthetic treatment according to the usual standards of practice at CHEO.
Andra namn:
|
Experimentell: A
Celebrex suspension
|
Patients will be randomized to receive celecoxib suspension 6 mg/kg one hour prior to their scheduled surgery. In addition the patient will receive seven weight-based doses of celecoxib (3 mg/kg) to be administered every 10-12 hours while the child is awake; the first dose being administered the evening of surgery. All participants will receive undergo and post surgery anesthetic treatment according to the usual standards of practice at CHEO.
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
The investigators primary objective will be to determine the level of postoperative pain relief celecoxib provides for children within the first three days after undergoing tonsillectomy, or adenotonsillectomy
Tidsram: three days
|
three days
|
Sekundära resultatmått
Resultatmått |
Tidsram |
---|---|
To measure the frequency of adverse events post surgery
Tidsram: For seven days immediately after the procedure
|
For seven days immediately after the procedure
|
To quantify the impact of celecoxib on fatigue
Tidsram: Day 0 before the procedure and again on Day 7 afterwards
|
Day 0 before the procedure and again on Day 7 afterwards
|
To quantify the impact of celecoxib on quality of life
Tidsram: Day 0 before the procedure and again on Day 7 afterwards
|
Day 0 before the procedure and again on Day 7 afterwards
|
To quantify the impact of celecoxib on pain relief postsurgery
Tidsram: Day 0 before the procedure and every day until Day 7 afterwards
|
Day 0 before the procedure and every day until Day 7 afterwards
|
To identify polymorphisms of CYP2C9 genotypes and their impact on pain relief.
Tidsram: Sample taken during the procedure
|
Sample taken during the procedure
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Kimmo Murto, MD, FRCPC, Children's Hospital of Eastern Ontario
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Patologiska processer
- Postoperativa komplikationer
- Smärta
- Neurologiska manifestationer
- Smärta, postoperativt
- Läkemedels fysiologiska effekter
- Molekylära mekanismer för farmakologisk verkan
- Agenter från det perifera nervsystemet
- Enzyminhibitorer
- Analgetika
- Sensoriska systemagenter
- Antiinflammatoriska medel, icke-steroida
- Analgetika, icke-narkotiska
- Antiinflammatoriska medel
- Antireumatiska medel
- Cyklooxygenashämmare
- Cyklooxygenas 2-hämmare
- Celecoxib
Andra studie-ID-nummer
- #09/10E
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Smärta, postoperativt
-
Örebro University, SwedenAvslutadPostoperativ smärtintensitet | Rescue Pain KravSverige
-
Korea University Anam HospitalKorea UniversityAvslutadSmärtmätning | Visual Analog Pain Scale
-
Alanya Alaaddin Keykubat UniversityAvslutadSterilisering, Tubal | Visual Analog Pain Scale
-
Turkish Ministry of Health, Kahramanmaras Provincial...RekryteringVisual Analog Pain ScaleKalkon
-
Ankara UniversityAvslutadSmärtmätning | Visual Analog Pain ScaleKalkon
-
East Carolina UniversityIndragen
-
University Hospital, GrenobleAvslutadDövhet | Visual Analog Pain ScaleFrankrike
-
Moens MaartenRekryteringMisslyckad Ryggkirurgi Syndrom | Persistent Spinal Pain Syndrome Typ 2Belgien
-
Moens MaartenVrije Universiteit BrusselRekryteringRyggmärgsstimulering | Persistent Spinal Pain Syndrome Typ 2Belgien
-
Wake Forest University Health SciencesRekryteringPhantom Limb Pain (PLP)Förenta staterna
Kliniska prövningar på Celebrex suspension
-
Ferring PharmaceuticalsRekrytering
-
The Methodist Hospital Research InstituteOkändVaginalvalvsframfall | Vaginalvalvsframfall efter hysterektomi | Framfall, vaginaltFörenta staterna
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RekryteringKronisk obstruktiv lungsjukdom (KOL)Kina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Rekrytering
-
AstraZenecaAvslutad
-
Santen Inc.AvslutadTorra ögonsjukdomFörenta staterna
-
Assiut UniversityOkänd
-
ParaPRO LLCConcentrics ResearchAvslutad
-
ParaPRO LLCConcentrics ResearchAvslutad
-
reMYNDRekryteringAlzheimers sjukdomNederländerna, Spanien